Related Experiment Video
Updated: Jun 7, 2025
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
13.7K
[Educational program to improve knowledge and therapeutic range for self-controlled anticoagulated patients].
Adolfo Romero-Arana1, María José González-Rodríguez2, Patricia Sánchez-Vega2
1Servicio Andaluz de Salud, Distrito Sanitario Costa del Sol, Málaga, España; Instituto de Investigaciones Biomédicas de Málaga (IBIMA-Bionand), Málaga, España.
Atencion Primaria
|November 13, 2024
Summary
An educational program significantly improved oral anticoagulation knowledge and time in therapeutic range (TTR) for self-controlled patients. This training enhances patient understanding and adherence to anticoagulation therapy.
Area of Science:
- Hematology
- Patient Education
- Pharmacology
Context:
- Self-control programs for oral anticoagulation have proven effective.
- Patients undergoing self-monitoring require continuous education to optimize therapy.
- Assessing knowledge and coagulation levels is crucial for patient management.
Purpose:
- To evaluate the impact of an educational intervention on patient knowledge.
- To assess changes in coagulation levels (Time in Therapeutic Range) post-intervention.
- To determine the effectiveness of educational programs for self-controlled anticoagulated patients.
Summary:
- A quasi-experimental study involving 145 patients evaluated an educational intervention on oral anticoagulation knowledge.
- Pre- and post-intervention tests showed significant improvements in patient knowledge scores (14.61 to 17.01).
- The Time in Therapeutic Range (TTR) also significantly improved from 67.46 to 70.53 post-intervention.
Impact:
- Educational interventions enhance patient knowledge of oral anticoagulation.
- Improved knowledge correlates with better coagulation control (TTR).
- This training is an effective strategy for optimizing self-controlled anticoagulation therapy.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
01:13Therapeutic Index
4.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.1K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
471
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
471
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:25Errors occurring during blood pressure monitoring
605
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
605